11 reports

  • Clinical Trial profile. 63 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Dermatological Condition
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 521 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Dermatological Condition
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Itch is often associated with sleep disorders, depression and anxiety and is cited as one of the most burdensome aspects of atopic dermatitis, as underscored during a recent Patient-Focused Drug Development meeting.

  • Clinical Trial
  • Dermatological Condition
  • Therapy
  • World
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Therapy
  • World
  • Novartis AG
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Dermatological Condition
  • Pathology
  • Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Therapy
  • World
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Therapy
  • World
  • Novartis AG
  • 5. All the trials included are unique trials.

Galectin-## plays a major role in diseases that involve scarring of organs including fibrotic disorders of the liver, lung, kidney, heart and vascular system.

  • Clinical Trial
  • Dermatological Condition
  • Pharmaceutical
  • World
  • Novartis AG
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Dermatological Condition
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative

Non-hematologic AEs included: general disorders and administration site conditions (## [##%]), gastrointestinal and metabolism/ nutrition disorders (## [##%] each), infections (## [##%]), respiratory/ thoracic disorders (## [##%]), vascular and skin/ subcutaneo

  • Cancer
  • Dermatological Condition
  • Targeted Therapy
  • Therapy
  • Novartis AG